Phytobezoar Associated with Levodopa-carbidopa Intestinal Gel Infusion in Patients with Parkinson’s Disease: A Case Report and Literature Review

2Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel (LCIG) is an established device-aided therapy for advanced Parkinson’s disease (PD). Phytobezoar associated with LCIG is a rare device-related complication and presents with exacerbations of gastrointestinal and PD symptoms. We herein report the case of a phytobezoar that was formed at a knot on the pigtail-shaped J-tube and developed only in association with postprandial abdominal pain, similar to a feeling of a tube being pulled in without an exacerbation of PD symptoms. Such abdominal pain may be a warning sign of phytobezoar in LCIG-treated patients. Despite device-related complications, high-pressure alarms are not always present, and PD symptoms are not always exacerbated.

Cite

CITATION STYLE

APA

Ueno, T., Hanabata, N., Katagai, A., Okudera, R., Arai, A., & Tomiyama, M. (2021). Phytobezoar Associated with Levodopa-carbidopa Intestinal Gel Infusion in Patients with Parkinson’s Disease: A Case Report and Literature Review. Internal Medicine. Japanese Society of Internal Medicine. https://doi.org/10.2169/internalmedicine.7210-21

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free